Exonate, Janssen to develop new eye drop

Exonate, a privately held, early stage, biotech company spun out of th...

January 14, 2020 | Tuesday | News
NBE-Therapeutics closes a $22M Series C financing round

NBE-Therapeutics AG announces the closing of a USD 22M Series C financ...

January 13, 2020 | Monday | News
Indapta, Lonza announce strategic partnership

Indapta Therapeutics, Inc., a biotechnology company focused on develop...

January 13, 2020 | Monday | News
MedLever and RaySearch announce interoperability agreement

MedLever announced that it has signed an agreement with RaySearch Labo...

January 10, 2020 | Friday | News
Blueprint Medicines wins FDA Approval of AYVAKIT to treat GIST

Blueprint Medicines Corporation, a precision therapy company focused o...

January 10, 2020 | Friday | News
BioMed X, Merck start new research program in autoimmune diseases

BioMed X has announced the start of a new joint research group in...

January 9, 2020 | Thursday | News
Schrödinger, Bayer focus on accelerating drug discovery

Schrödinger and Bayer have announced a five-year technology allia...

January 9, 2020 | Thursday | News
Lannett launches Venlafaxine ER tablets and Lidocaine topical solution 4%

Lannett Company, Inc. has commenced marketing Venlafaxine Extended Rel...

January 8, 2020 | Wednesday | News
ProBioGen inks next commercial GlymaxX license with Roche

ProBioGen AG has signed a commercial license agreement with Roche...

January 8, 2020 | Wednesday | News
Merck strengthens CRISPR/Cas9 strategic alliance with GenOway

genOway, a leading company in the development of genetically modified ...

January 7, 2020 | Tuesday | News
MiNA Therapeutics announces research collaboration with AstraZeneca

UK based MiNA Therapeutics has announced the initiation of a research ...

January 8, 2020 | Wednesday | News
Velabs Therapeutics receives exclusive licence for development of therapeutic antibodies

Velabs Therapeutics, a biotech company focused on the rapid screening ...

January 7, 2020 | Tuesday | News
Polyganics achieves CE Mark certification for LIQOSEAL®

Polyganics, a medical technology company developing, manufacturing and...

January 7, 2020 | Tuesday | News
Global Cancer Immunotherapy to hit $115 Bn by 2023

Immunotherapy is forecast to become the oncology treatment of choice b...

January 7, 2020 | Tuesday | Reports/white papers
Merck forms strategic oncology link with Taiho, Astex

Merck, known as MSD outside the United States and Canada, has announce...

January 7, 2020 | Tuesday | News
Molina acquires NextLevel Health Partners

Molina Healthcare has entered into a definitive agreement to acquire a...

January 6, 2020 | Monday | News
Ebb Therapeutics to launch wearable technology for sleeplessness

Ebb Therapeutics is on a mission to make an impact in both the pr...

January 6, 2020 | Monday | News
Biostage gives update on FDA Investigational NDA for Cellspan Esophageal Implant

Biostage, a bioengineering company developing next-generation esophage...

January 6, 2020 | Monday | News

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy